Literature DB >> 4362485

Doxorubicin in treatment of malignant solid tumors in children.

C B Pratt, E C Shanks.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4362485     DOI: 10.1001/archpedi.1974.02110230080012

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


× No keyword cloud information.
  8 in total

Review 1.  Relevance of historical therapeutic approaches to the contemporary treatment of pediatric solid tumors.

Authors:  Daniel M Green; Larry E Kun; Katherine K Matthay; Anna T Meadows; William H Meyer; Paul A Meyers; Sheri L Spunt; Leslie L Robison; Melissa M Hudson
Journal:  Pediatr Blood Cancer       Date:  2013-02-15       Impact factor: 3.167

2.  Systolic time interval as index of schedule--dependent doxorubicin cardiotoxicity in patients with acute myelogenous leukaemia.

Authors:  S Al-Ismail; J A Whittaker
Journal:  Br Med J       Date:  1979-05-26

3.  A phase I study of oxaliplatin and doxorubicin in pediatric patients with relapsed or refractory extracranial non-hematopoietic solid tumors.

Authors:  Leo Mascarenhas; Marcio Malogolowkin; Saro H Armenian; Richard Sposto; Rajkumar Venkatramani
Journal:  Pediatr Blood Cancer       Date:  2013-01-17       Impact factor: 3.167

4.  High Throughput Screening Identifies a Novel Compound Protecting Cardiomyocytes from Doxorubicin-Induced Damage.

Authors:  Szabolcs Gergely; Csaba Hegedűs; Petra Lakatos; Katalin Kovács; Renáta Gáspár; Tamás Csont; László Virág
Journal:  Oxid Med Cell Longev       Date:  2015-06-07       Impact factor: 6.543

Review 5.  Pediatric Osteosarcoma: An Updated Review.

Authors:  Shachi Jain Taran; Rakesh Taran; Nagraj B Malipatil
Journal:  Indian J Med Paediatr Oncol       Date:  2017 Jan-Mar

6.  A population-based analysis of the presentation and outcomes of pediatric patients with osteosarcoma in Canada: a report from CYP-C.

Authors:  Michael J Horkoff; Joseph K Kendal; Christopher Blackmore; Tony H Truong; Gregory M T Guilcher; Mary E Brindle
Journal:  Can J Surg       Date:  2022-08-12       Impact factor: 2.840

7.  Outcome and toxicity of an Ifosfamide-based soft tissue sarcoma treatment protocol in children. The importance of local therapy.

Authors:  S M Yule; R Skinner; M W English; M Cole; A D Pearson; H H Lucraft; A W Craft
Journal:  Sarcoma       Date:  1998

8.  Radiation Dose Escalation is Crucial in Anti-CTLA-4 Antibody Therapy to Enhance Local and Distant Antitumor Effect in Murine Osteosarcoma.

Authors:  Wataru Takenaka; Yutaka Takahashi; Keisuke Tamari; Kazumasa Minami; Shohei Katsuki; Yuji Seo; Fumiaki Isohashi; Masahiko Koizumi; Kazuhiko Ogawa
Journal:  Cancers (Basel)       Date:  2020-06-12       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.